Ebola Archives -

Amidst the COVID-19 pandemic, West Africa is facing a new outbreak of Ebola. A global emergency stockpile of

West Africa prepares for Ebola vaccination program

https://pharmaphorum.com/views-and-analysis/west-africa-prepares-for-ebola-vaccination-program/

News/ News/ Patients

Guinea declares Ebola epidemic following first deaths since 2016

Richard Staines Ebola, infectious diseases, Merck & Co, vaccine 0 Comment

Guinea has officially declared it is dealing with an Ebola epidemic, after at least three people died from

Guinea declares Ebola epidemic following first deaths since 2016

https://pharmaphorum.com/news/guinea-declares-ebola-epidemic-following-first-deaths-since-2016/

Market Access/ News/ News

Regeneron’s antibody cocktail approved by FDA for Ebola

Richard Staines COVID-19, Ebola, infectious diseases, Regeneron 0 Comment

An antibody cocktail from Regeneron has been approved by the FDA as the first treatment for Ebola, offering

Regeneron’s antibody cocktail approved by FDA for Ebola

https://pharmaphorum.com/news/regenerons-antibody-cocktail-approved-by-fda-for-ebola/

Market Access/ News/ News/ Top stories

Regeneron’s Ebola drug heading for October verdict from FDA

Phil Taylor antibody, Ebola, fda, infectious disease, Regeneron 0 Comment

The FDA has kicked off a six-month priority review of REGN-EB3, Regeneron’s three-drug therapy for Ebola virus infection,

Regeneron’s Ebola drug heading for October verdict from FDA

https://pharmaphorum.com/news/regenerons-ebola-drug-heading-for-october-verdict-from-fda/

Market Access/ News/ News

Merck claims first-ever FDA approval for an Ebola vaccine

Phil Taylor Ebola, fda, Merck & Co, vaccine 0 Comment

Merck & Co’s Ebola vaccine Ervebo has been cleared for marketing in the US, just weeks after getting

Merck claims first-ever FDA approval for an Ebola vaccine

https://pharmaphorum.com/news/merck-claims-first-ever-fda-approval-for-an-ebola-vaccine/

Market Access/ News/ News

CHMP backs world’s first Ebola vaccine from MSD, NewLink

Phil Taylor Ebola, Merck & Co, vaccine 0 Comment

Merck & Co/MSD’s Ebola vaccine has been recommended for conditional approval by the EMA’s main advisory committee, teeing

CHMP backs world’s first Ebola vaccine from MSD, NewLink

https://pharmaphorum.com/news/chmp-backs-worlds-first-ebola-vaccine-from-msd-newlink/

News/ News/ R&D

Merck & Co in pole position for Ebola vaccine approval as FDA begins review

Richard Staines Ebola, infectious diseases, Merck & Co 0 Comment

The FDA is to review Merck & Co’s Ebola vaccine, giving the US pharma a chance to grab

Merck & Co in pole position for Ebola vaccine approval as FDA begins review

https://pharmaphorum.com/news/fda-to-review-merck-cos-ebola-vaccine/

News/ News/ R&D

First effective Ebola treatment a step closer after breakthrough trial

Joy Persaud Ebola, Regeneron, Ridgeback, WHO 0 Comment

Clinical trials of four experimental treatments for Ebola in the Congo have been halted early after two of

First effective Ebola treatment a step closer after breakthrough trial

https://pharmaphorum.com/news/ebola-virus-clinical-trial-breakthrough/

News/ News/ R&D

GSK exits Ebola vaccine R&D as J&J rival starts Uganda trial

Phil Taylor Ebola, GlaxoSmithKline, infectious disease, Johnson & Johnson, vaccine 0 Comment

GlaxoSmithKline has licensed vaccines for Ebola to the US Sabin Vaccine Institute, just as a major trial of

GSK exits Ebola vaccine R&D as J&J rival starts Uganda trial

https://pharmaphorum.com/news/gsk-exits-ebola-vaccine-rd-as-jj-rival-starts-uganda-trial/

Trending

Ebola

Login